跳至主要内容
临床试验/ISRCTN34303497
ISRCTN34303497已完成不适用

A phase II non-randomised study of medroxyprogesterone acetate plus bezafibrate as adjunctive therapy in the treatment of relapsed Burkitt's lymphoma in Blantyre, Malawi

niversity of Malawi (Malawi)0 个研究点目标入组 40 人开始时间: 2009年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged less than 14 years, either sex
  • 2. Diagnosis of relapsed Burkitt's lymphoma confirmed by cytology/immunophenotyping
  • 3. Negative pregnancy test if the patient is of childbearing potential
  • 4. Informed consent, and the ability of the guardian and patient to co-operate with treatment and follow up must be ensured and documented

排除标准

  • 1. Patient unable to swallow tablets
  • 2. Patients living outside Malawi (follow up is not possible for patients living in Mozambique)
  • 3. Pregnancy
  • 4. Breast feeding

研究者

发起方
niversity of Malawi (Malawi)

相似试验